Friday, September 14, 2018

Sun Pharma gets USFDA nod for eye drug Xelpros

XELPROS will be commercialized in the US by Sun Ophthalmics, the branded ophthalmic division of Sun Pharmaceutical Industries Ltd.s wholly owned subsidiary.

from India Infoline News Service https://ift.tt/2OfuITI
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)